Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:06 AM
Ignite Modification Date:
2025-12-25 @ 2:06 AM
NCT ID:
NCT00002260
Eligibility Criteria:
Inclusion Criteria
Patients must have:
* Positive ELISA test confirmed by Western blot analysis.
* Asymptomatic.
* Willing to sign an informed consent.
Exclusion Criteria
Co-existing Condition:
Patients with the following conditions or symptoms are excluded:
* Oral candida infection documented by morphology or by a response to antifungal therapy within two months prior to study entry.
* Oral hairy leukoplakia at any time prior to entry.
* Temperature \> 37.8 C.
* Any malignancy other than cutaneous basal cell carcinoma or cervical carcinoma in situ.
* Significant chronic underlying medical illness which would prevent continuous participation in this clinical trial.
* Unwilling to sign an informed consent.
* Zidovudine induced hematological toxicity.
Prior Medication:
Excluded:
* Therapy with antiretroviral drugs or immunomodulators within seven days before entry.
* Therapy with any investigational drug during the preceding 30 days.
Patients may not have:
* Oral candida infection documented by morphology or by a response to antifungal therapy within two months prior to study entry.
* Oral hairy leukoplakia at any time prior to entry.
* Temperature \> 37.8 C.
* Any malignancy other than cutaneous basal cell carcinoma or cervical carcinoma in situ.
* Significant chronic underlying medical illness which would prevent continuous participation in this clinical trial.
* Unwilling to sign an informed consent.
* Zidovudine induced hematological toxicity.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT00002260
Study Brief:
Protocol Section:
NCT00002260